Screener
Apogee Therapeutics, Inc. APGE Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Apogee Therapeutics, Inc.’s reported figures.
The source filing: Apogee Therapeutics, Inc.’s 10-K, filed March 2, 2026. Open the filing →
- Filed
- Mar 2, 2026, 7:20 AM EST
- Fiscal year
- FY2025
- Accession
- 0001974640-26-000002
FAQ
- What is Apogee Therapeutics, Inc.'s free cash flow?
- Apogee Therapeutics, Inc. (APGE) reported free cash flow of -$62.75M in Q4 2025.
- How has Apogee Therapeutics, Inc.'s free cash flow changed year-over-year?
- Apogee Therapeutics, Inc.'s free cash flow increased by 7.3% year-over-year, from -$67.71M to -$62.75M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s free cash flow?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s free cash flow has grown at a 76.2% compound annual growth rate (CAGR), from -$74.93M to -$232.6M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Apogee Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude